| Code | Name | Last | Change(%) | P/E | Yield (%) | P/E Range | ||
| APLS | Apellis Pharmaceuticals |  | -- | -- | -- | -- | ||
| Pre Market |  | 19.64 | +0.56% | |||||
| ANVS | Annovis Bio | | -- | -- | -- | -- | ||
| Pre Market | | 2.86 | +0.35% | |||||
| ANNX | Annexon | | -- | -- | -- | -- | ||
| Pre Market |  | 2.6 | -7.14% | |||||
| ANIX | Anixa Biosciences | | -- | -- | -- | -- | ||
| Pre Market | | 3.0745 | -2.09% | |||||
| ANEB | Anebulo Pharmaceuticals | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| AVXL | Anavex Life Sciences Corp | | -- | -- | -- | -- | ||
| Pre Market | | 11.2402 | +0.54% | |||||
| ANAB | AnaptysBio | | -- | -- | -- | -- | ||
| Pre Market | | 26 | -0.34% | |||||
| AMLX | Amylyx Pharmaceuticals | | -- | -- | -- | -- | ||
| Pre Market | | 7.51 | +1.62% | |||||
| FOLD | Amicus Therapeutics | | -- | -- | -- | -- | ||
| Pre Market | | 6.37 | +1.11% | |||||
| ALZN | Alzamend Neuro Inc. | | -- | -- | -- | -- | ||
| Pre Market | | 3.08 | +0.98% | |||||
| ALMS | Alumis Inc. | | -- | -- | -- | -- | ||
| Pre Market | | 3.58 | +0.56% | |||||
| ANRO | Alto Neuroscience | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ALT | Altimmune | | -- | -- | -- | -- | ||
| Pre Market | | 4.34 | -1.36% | |||||
| ATHE | Alterity Therapeutics Limited | | -- | -- | -- | -- | ||
| Pre Market | | 4.5985 | +18.21% | |||||
| DRTS | Alpha Tau Medical Ltd | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ACOG | Alpha Cognition Inc | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ALNY | Alnylam Pharmaceuticals | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
| ALLO | Allogene Therapeutics | | -- | -- | -- | -- | ||
| Pre Market | | 1.29 | +2.38% | |||||
| ALLR | Allarity Therapeutics Inc | | -- | -- | -- | -- | ||
| Pre Market | | 1.04 | -3.70% | |||||
| ALGS | Aligos Therapeutics Inc | | -- | -- | -- | -- | ||
| Pre Market | | -- | -- | |||||
 | Quotes are at least 15-min delayed：2025/07/11 09:16 EDT |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |
